ClinVar Miner

Submissions for variant NM_032043.3(BRIP1):c.1184C>T (p.Ala395Val)

dbSNP: rs778992385
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000533050 SCV000633539 uncertain significance Familial cancer of breast; Fanconi anemia complementation group J 2022-05-08 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 461064). This variant has not been reported in the literature in individuals affected with BRIP1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 395 of the BRIP1 protein (p.Ala395Val).
Ambry Genetics RCV001010086 SCV001170234 uncertain significance Hereditary cancer-predisposing syndrome 2024-05-24 criteria provided, single submitter clinical testing The p.A395V variant (also known as c.1184C>T), located in coding exon 8 of the BRIP1 gene, results from a C to T substitution at nucleotide position 1184. The alanine at codon 395 is replaced by valine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. This alteration was identified in 1/6341 breast cancer patients, 0/706 ovarian cancer patients, and 1/2189 matched controls (Weber-Lassalle N et al. Breast Cancer Res., 2018 Jan;20:7). In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Institute of Human Genetics, University of Leipzig Medical Center RCV001262879 SCV001440913 uncertain significance Familial cancer of breast 2019-01-01 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.